Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Christiane L Haase"'
Autor:
Sean Wharton, Christiane L Haase, Elham Kamran, Aiden Liu, Johanna Mancini, Drew Neish, Arash Pakseresht, G Sarah Power, Rebecca AG Christensen
Publikováno v:
Obesity Science & Practice, Vol 6, Iss 4, Pp 382-389 (2020)
Summary Objective Weight management medications can significantly increase patients' chances of achieving a clinically meaningful weight loss if patients persist with treatment. This retrospective observational study of de‐identified medical record
Externí odkaz:
https://doaj.org/article/b1e41395ee644095b92b842ca20e8a0b
Publikováno v:
PLoS Genetics, Vol 8, Iss 11, p e1003063 (2012)
Rare genetic variants, identified by in-detail resequencing of loci, may contribute to complex traits. We used the apolipoprotein A-I gene (APOA1), a major high-density lipoprotein (HDL) gene, and population-based resequencing to determine the spectr
Externí odkaz:
https://doaj.org/article/db5d434f85974858bd3ea80ba1c7f587
Autor:
Christiane L. Haase, Kirsten T. Eriksen, Sandra Lopes, Altynai Satylganova, Volker Schnecke, Phil McEwan
Publikováno v:
Obesity Science & Practice, Vol 7, Iss 2, Pp 137-147 (2021)
Abstract Objective Obesity rates in the United Kingdom are some of the highest in Western Europe, with considerable clinical and societal impacts. Obesity is associated with type 2 diabetes (T2D), osteoarthritis, cardiovascular disease, and increased
Externí odkaz:
https://doaj.org/article/e12f15b22d104809b8dfa8a3d144d27b
Autor:
Orna Reges, Dror Dicker, Christiane L. Haase, Nick Finer, Tomas Karpati, Morton Leibowitz, Altynai Satylganova, Becca Feldman
Publikováno v:
Obesity Science & Practice, Vol 7, Iss 2, Pp 148-158 (2021)
Abstract Objective Previous studies using longitudinal weight data to characterize obesity are based on populations of limited size and mostly include individuals of all body mass index (BMI) levels, without focusing on weight changes among people wi
Externí odkaz:
https://doaj.org/article/de7833b3587743568a5006968603f863
Autor:
Volker Schnecke, Christiane L Haase, Phil McEwan, Anne Helene Olsen, Sandra Lopes, Altynai Satylganova
Publikováno v:
International Journal of Obesity (2005)
High body mass index (BMI) is known to be associated with various conditions, including type 2 diabetes (T2D), osteoarthritis, cardiovascular disease (CVD) and sleep apnoea; however, the impact of intentional weight loss on the risk of these and othe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea5bae9392f475ec5cfbe6658cf823fc
https://doi.org/10.1038/s41366-021-00788-4
https://doi.org/10.1038/s41366-021-00788-4
Autor:
Anne Helene Olsen, Carel W. le Roux, Altynai Satylganova, Christiane L Haase, Niels V. Hartvig, Rikke B. Nordsborg
Publikováno v:
European Journal of Preventive Cardiology. 28:1235-1241
Aims Obesity and cardiovascular diseases (CVDs) often co-occur, likely increasing the intensity of healthcare resource utilization (HCRU). This retrospective, observational database study examined the joint effect of obesity and cardiovascular risk s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d42fad46f86e5420cf98f68d8c12d35
https://doi.org/10.1177/2047487320925639
https://doi.org/10.1177/2047487320925639
Autor:
G Sarah Power, Aiden Liu, Elham Kamran, Arash Pakseresht, Sean Wharton, Drew Neish, Rebecca A. G. Christensen, Christiane L Haase, Johanna Mancini
Publikováno v:
Obesity Science & Practice, Vol 6, Iss 4, Pp 439-444 (2020)
Obesity Science & Practice
Obesity Science & Practice
Summary Objective Liraglutide 3.0 mg is associated with clinically significant weight loss in clinical trials, but real‐world data are lacking. In this analysis, weight loss and persistence outcomes with liraglutide 3.0 mg were assessed across obes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04edfd3aa95e3512539f98a383874289
https://doi.org/10.1002/osp4.420
https://doi.org/10.1002/osp4.420
Autor:
Gianluca Lucrezi, Susanne Maurer, Maria Giovanna Serratore Achenbach, Ulrich Egermann, Nikita Jeswani, Christiane L Haase
Publikováno v:
Obes Facts
Obesity Facts, Pp 1-9 (2021)
Obesity Facts, Pp 1-9 (2021)
Introduction: Data from randomized controlled trials show that liraglutide 3.0 mg, in combination with diet and exercise, is associated with greater weight loss than diet and exercise alone in patients with obesity. In practice, the utilization of we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c06bcbb8c8adf2b476d09704b0b171d
https://pubmed.ncbi.nlm.nih.gov/34515194
https://pubmed.ncbi.nlm.nih.gov/34515194
Autor:
Christiane L Haase, Dror Dicker, Morton Leibowitz, Tomas Karpati, Orna Reges, Nick Finer, Altynai Satylganova, Becca Feldman
Publikováno v:
Obesity Science & Practice
Obesity Science & Practice, Vol 7, Iss 2, Pp 148-158 (2021)
Obesity Science & Practice, Vol 7, Iss 2, Pp 148-158 (2021)
Objective Previous studies using longitudinal weight data to characterize obesity are based on populations of limited size and mostly include individuals of all body mass index (BMI) levels, without focusing on weight changes among people with obesit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa9c2dd7da2ee7248e0a63a04442012f
https://pubmed.ncbi.nlm.nih.gov/33841884
https://pubmed.ncbi.nlm.nih.gov/33841884
Autor:
Kirsten T. Eriksen, Volker Schnecke, Sandra Lopes, Christiane L Haase, Altynai Satylganova, Phil McEwan
Publikováno v:
Obesity Science & Practice
Obesity Science & Practice, Vol 7, Iss 2, Pp 137-147 (2021)
Obesity Science & Practice, Vol 7, Iss 2, Pp 137-147 (2021)
Objective Obesity rates in the United Kingdom are some of the highest in Western Europe, with considerable clinical and societal impacts. Obesity is associated with type 2 diabetes (T2D), osteoarthritis, cardiovascular disease, and increased mortalit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::336a56d27c2af3783ed0acea6615ac69
https://pubmed.ncbi.nlm.nih.gov/33841883
https://pubmed.ncbi.nlm.nih.gov/33841883